HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 2350Erstellt: 26. Oktober 2026
4-((4-Chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic Acid
rac Bepotastine · Rac-Bepotastine-d6 · YWGDOWXRIALTES-UHFFFAOYSA-N · 4-[(4-Chlorophenyl)-2-pyridinylmethoxy]-1-piperidinebutanoic acid · 1-Piperidinebutanoic acid, 4-[(4-chlorophenyl)-2-pyridinylmethoxy]-
https://huagongshe.com/de/chemical/2350
Identifikatoren & physikalische Daten
| CAS No. | 1070505-53-1 |
|---|
| Summenformel | C21H25ClN2O3 |
|---|
| Durchschnittliche Molmasse | 388,9 g/mol |
|---|
| Monoisotopische Masse | 388,15537034 g/mol |
|---|
| SMILES | O=C(O)CCCN1CCC(OC(c2ccc(Cl)cc2)c2ccccn2)CC1 |
|---|
| InChIKey | YWGDOWXRIALTES-UHFFFAOYSA-N |
|---|
| PubChem CID | 2350 |
|---|
| ChEMBL | CHEMBL4877190 |
|---|
| DTXSID | DTXSID70869727 |
|---|
Chemische & physikalische Eigenschaften
| XLogP | 1 |
|---|
| Polarare Oberfläche (TPSA) | 62,7 |
|---|
| H-Brücken-Donoren | 1 |
|---|
| H-Brücken-Akzeptoren | 5 |
|---|
| Frei drehbare Bindungen | 8 |
|---|
| Schwere Atome | 27 |
|---|
| Formalladung | 0 |
|---|
| Komplexität | 449 |
|---|
| Löslichkeit | 5.03e-02 g/L |
|---|
| Physical Description | Solid |
|---|
| Dichte | 1.26 |
|---|
Sicherheit & Vorschriften
| Expositionspfade | Oral, Ophthalmic. Tmax, after single dose, opthalmic = 1.2 hoursCmax, 1.5%, opthalmic dose = 7.3 ۫.9 ng/mLAfter 24 hours post-installation, levels of bepotastine are below quantifiable limit of 2 ng/mL. Minimal systemic absorption with opthalmic dosage form. |
|---|
| Toxizitätsübersicht | Because of a type 1 hypersensitivity reaction cascade that is triggered by antigen exposure, allergic conjunctivitis occurs. Allergen exposure is followed by conjunctival mast cell degranulation and histamine released as a result of the formation of complementary IgE cross-links on the conjunctiva. Due to the release of histamine, symptoms such as itching can be observed. Bepotastine works to relieve itchy eyes by three primary mechanisms of action. It is a non-sedating, selective antagonist of the histamine 1 (H1) receptor, a mast cell stabilizer, and it suppresses the migration of eosinophils into inflamed tissues to prevent tissue damage and worsening of allergic inflammation of the conjunctiva. |
|---|
| Carcinogen Classification | No indication of carcinogenicity to humans (not listed by IARC). |
|---|